BioRails Biohub has been selected by a global Biopharmaceutical company based in Boston, MA to provide a central results hub for all their research. After a lengthy selection process the Edge was selected as providing the best solution (BioRails), the knowledge and expertise required to successfully deliver the next generation of research system. The project will not only ensure new research can be exploited to move forward the companies portfolio but also to migrate all their historic results from two legacy systems.
Work started in 2019 and will be completed by the end of 2020.
Andrew Lemon, CEO said, “We are extremely excited to be working with such a prestigious company, and that they recognised our expertise and quality in selecting us. This is another important marker in our 15 year history. We look forward to a long and fruitful partnership with the companies great team.”